Announcing OMF's First ME/CFS Clinical Trial!

Get the details
Main Menu
Donate
Sign Up

Skeletal Muscle Dysfunction Research

Study AIM

This Harvard study explored the biological changes that occur in the muscles during Post-exertional Malaise (PEM). The Computation Center is now seeking to identify drug targets to prevent PEM.

LEAD INVESTIGATORS
  • Wenzhong Xiao, PhD
  • Philip Atherton, PhD
  • Paul Greenhaff, PhD
  • David Systrom, MD
Updates and Potential
  • 95 skeletal muscle samples have been studied using Illumina RNA-seq systems by NovoGene
  • There were two studies of healthy aging subjects:
    • 2 weeks bedrest [younger (18-30 years) vs. older (55-65 years)]
      • The older subjects had tremendous genomic response compared to the younger cohort
      • The pathways involved were consistent with immobility
      • Two weeks of physical rehabilitation reversed these genomics
    • 2 months bedrest (young 34 ± 1.8 years)
      • In younger subjects, a comparable genomic response mirrored those changes seen in the two-week study in the older cohort
      • These genomic changes were consistent with those seen after two weeks of bedrest in the older cohort.

The skeletal muscle genomics have been completed and the analysis is underway to include metabolic modelling. Click here to find out more.

STUDY HYPOTHESIS AND DESCRIPTION

Powerful genomic research tools used to understand cancer and heart disease might also help us understand why people with ME/CFS develop post-exertional malaise (PEM). The way that genes in ME/CFS patients behave differently from those in healthy comparable subjects might give tremendous insight for a biomarker or drug targets to combat PEM and fatigue.

The hypothesis is that the inflammation-related recovery mechanisms become dysfunctional in the ME/CFS disease, and this dysregulation causes delayed muscle recovery after exertional stress.

This hypothesis will be tested by analysing nearly 100 muscle biopsy samples from healthy subjects whose ages, sex, and lifestyles match those of ME/CFS patients as closely as possible. Careful comparison to these samples will be critical to detect subtle differences in the genes responsible for a healthy recovery from muscular exercise.

OBJECTIVES

  • Muscle biopsy samples will be taken from ME/CFS patients both at rest and eventually during their recovery from mild to moderate muscular stress.
  • Comparisons will be made to healthy volunteers also at rest, during recovery from muscular stress, and during immobilization.
  • Using muscle samples, this study will examine the following:
    • Genomics
    • Proteomics
    • Metabolomics
    • Phospho-proteomics
    • Ultrastructural analysis
    • Mitobiogenetic markers.
Other links you might be interested in:
Collaborative Research Center Stanford
Digital Fundraising Toolkit
Facebook Twitter Youtube Instagram Linkedin

OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the extent allowed by law.

Open Medicine Foundation®
29302 Laro Drive,  Agoura Hills, CA 91301 USA
Phone: 650-242-8669
info@omf.ngo

Contact Us

PRIVACY  |  COOKIE   |   CONSENT   |  MEDICAL & OTHER DISCLAIMERS

Copyright © 2023 Open Medicine Foundation. All Rights Reserved.

Consent management

Consent Preferences

Data Subject Access Request (DSAR) Form 

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669 
 
Donate